Cell-Free Protein Synthesis (CFPS)
Plain-language role: Use this skill to plan expression screens and improve yield or solubility in cell-free systems.
System Selection Guide
| System |
Best For |
Yield |
PTMs |
Disulfides |
Cost |
| E. coli extract |
Rapid prototyping, prokaryotic proteins |
High (100-400 μg/mL) |
None |
Poor (reducing) |
Low |
| E. coli PURE |
Defined conditions, unnatural AAs |
Medium (50-150 μg/mL) |
None |
Controllable |
High |
| Wheat germ |
Eukaryotic proteins, membrane proteins |
High (100-500 μg/mL) |
Limited |
Moderate |
Medium |
| Rabbit reticulocyte |
Mammalian proteins, post-translational studies |
Low (10-50 μg/mL) |
Some |
Poor |
High |
| Insect (Sf21) |
Glycoproteins, complex folds |
Medium (50-100 μg/mL) |
Glycosylation |
Good |
High |
| HeLa/CHO |
Native mammalian proteins |
Low (10-50 μg/mL) |
Full mammalian |
Good |
Very High |
CFPS Troubleshooting Matrix
| Problem |
Likely Causes |
Design Fix |
Reagent Fix |
| No expression |
Rare codons at N-terminus, poor RBS |
Codon optimize first 30 codons |
Use BL21-CodonPlus extract |
| Low yield |
Strong mRNA secondary structure, template issues |
Optimize 5' UTR (ΔG > -5 kcal/mol) |
Increase Mg²⁺ (10-18 mM), ATP |
| Aggregation |
Hydrophobic protein, fast translation |
Add solubility tags (MBP, SUMO) |
Add 0.1% Tween-20, chaperones |
| Inactive protein |
Misfolding, missing cofactors |
Slow translation (use rare codons!) |
Add GroEL/ES, DnaK/J |
| Truncation |
Rare codon clusters, mRNA instability |
Remove AGG/AGA/CUA clusters |
Supplement rare tRNAs |
| Degradation |
Proteolysis |
N-terminal Met-Ala |
Add protease inhibitors |
Codon Optimization for CFPS
Codons to Avoid in E. coli CFPS
| Codon |
Amino Acid |
Issue |
tRNA Abundance |
| AGG |
Arg |
Very rare, stalling |
0.2% |
| AGA |
Arg |
Very rare, stalling |
0.4% |
| CUA |
Leu |
Low abundance |
0.4% |
| AUA |
Ile |
Rare |
0.5% |
| CGA |
Arg |
Inefficient decoding |
0.6% |
| CCC |
Pro |
Can cause pausing |
0.5% |
| GGA |
Gly |
Moderate |
1.1% |
Design Rules
- First 30 codons: Most critical - use only high-frequency codons
- Rare codon clusters: Avoid 2+ rare codons within 10 nt
- Rare codon content: Keep overall <5% of coding sequence
- GC content: Target 40-60% for balanced expression
- Avoid runs: No >6 consecutive G or C residues (secondary structure)
- Strategic slow codons: Place rare codons between domains (aids folding!)
When to Use Rare Codons
- Domain boundaries (allow cotranslational folding)
- Before complex structural elements
- When protein is prone to misfolding
mRNA Template Design
5' UTR Optimization
| Element |
Optimal Design |
Impact |
| RBS (SD sequence) |
AGGAGG, 7-9 nt from start |
Ribosome binding |
| Spacing |
7 nt between SD and AUG |
Translation initiation |
| Secondary structure |
ΔG > -5 kcal/mol |
Accessibility |
| Upstream AUG |
Avoid (causes false starts) |
Reduces truncations |
Secondary Structure Targets
| Region |
Ideal ΔG |
Impact |
| -30 to +30 around AUG |
> -5 kcal/mol |
Translation initiation |
| Full 5' UTR |
> -10 kcal/mol |
Ribosome loading |
| RBS accessibility |
Unpaired |
Critical |
Template Format
| Format |
Advantages |
Disadvantages |
| Plasmid |
Stable, high yield |
Requires cloning |
| Linear PCR |
Fast, no cloning |
May need stabilization |
| mRNA |
Direct translation |
Unstable, expensive |
Disulfide Bond Formation
System Capabilities
| System |
Native Disulfide Support |
Additives Needed |
| Standard E. coli extract |
Poor (DTT present) |
IAM, PDI, GSSG/GSH |
| Oxidizing E. coli extract |
Good |
Pre-oxidized glutathione |
| Wheat germ |
Moderate |
Lower DTT, add PDI |
| PURE system |
Minimal |
Full oxidative system |
| Insect/Mammalian |
Good |
Microsome membranes |
Oxidative Folding Protocol (E. coli extract)
1. Deplete DTT from extract (dialysis or treatment with IAM 5 mM)
2. Add oxidized/reduced glutathione: 4 mM GSSG, 1 mM GSH (4:1 ratio)
3. Add 10 μM PDI (protein disulfide isomerase)
4. Optional: Add 5 μM DsbC (disulfide isomerase)
5. Express at 25°C (not 37°C) for better folding
6. Incubation time: 4-6 hours
Disulfide-Rich Protein Tips
- Start with wheat germ or oxidizing extract
- Use PURE system for precise control
- Consider co-expression of PDI/DsbC
- Verify by non-reducing SDS-PAGE
Expression Prediction from Sequence
| Feature |
Good |
Marginal |
Bad |
| Rare codon content |
<3% |
3-8% |
>10% |
| First 30 codons rare |
0 |
1-2 |
>2 |
| GC content |
45-55% |
35-45% or 55-65% |
<30% or >70% |
| 5' UTR ΔG |
> -3 kcal/mol |
-3 to -8 |
< -10 kcal/mol |
| Hydrophobic stretches |
<5 consecutive |
5-7 |
>8 consecutive |
| N-terminal residue |
Met-Ala, Met-Ser, Met-Gly |
Met-Val, Met-Thr |
Met-Arg, Met-Lys |
| Cysteine pairs |
Paired (even number) |
Mixed |
Odd number (free thiols) |
Solubility Enhancement Strategies
Fusion Tags (ranked by effectiveness)
| Tag |
Size |
Solubility Enhancement |
Cleavage |
Notes |
| MBP |
40 kDa |
Excellent |
TEV, Factor Xa |
Best overall |
| SUMO |
11 kDa |
Very Good |
SUMO protease |
Native N-terminus after cleavage |
| NusA |
55 kDa |
Excellent |
- |
Large size |
| Trx |
12 kDa |
Good |
Enterokinase |
For disulfide proteins |
| GST |
26 kDa |
Moderate |
- |
Dimeric |
| His₆ |
1 kDa |
Minimal |
- |
Mainly for purification |
Buffer Additives for Solubility
| Additive |
Concentration |
Mechanism |
| Trehalose |
50-100 mM |
Chemical chaperone |
| Glycerol |
5-10% |
Reduces hydrophobic aggregation |
| L-Arginine |
50-100 mM |
Suppresses aggregation |
| Tween-20 |
0.05-0.1% |
Prevents surface adsorption |
| Proline |
50 mM |
Osmolyte stabilization |
Chaperone Supplementation
| Chaperone System |
Target Problem |
Concentration |
| GroEL/GroES |
General folding |
1-2 μM |
| DnaK/DnaJ/GrpE |
Aggregation-prone |
1 μM each |
| Trigger Factor |
Nascent chain |
1-2 μM |
| ClpB |
Aggregate resolubilization |
0.5 μM |
Temperature Optimization
| Temperature |
Use Case |
Trade-offs |
| 37°C |
Fast expression, stable proteins |
Higher aggregation risk |
| 30°C |
Balanced (default) |
Good compromise |
| 25°C |
Disulfide proteins, complex folds |
Slower, better folding |
| 18-20°C |
Aggregation-prone proteins |
Much slower, best folding |
| 16°C |
Cold-shock proteins |
Very slow, specialized |
E. coli Extract Preparation (Key Variables)
| Variable |
Impact |
Optimal Range |
| Cell density at harvest |
Ribosome content |
OD₆₀₀ 2.5-3.5 |
| Lysis method |
Extract activity |
Sonication, bead beating |
| Run-off reaction |
Removes endogenous mRNA |
20-80 min at 37°C |
| Mg²⁺ concentration |
Translation fidelity |
10-18 mM |
| K⁺ concentration |
Translation rate |
150-200 mM |
| Energy system |
Sustained synthesis |
ATP/GTP, creatine phosphate |
PURE System Specifics
Advantages
- Defined composition (no proteases/nucleases)
- Linear DNA templates work well
- Unnatural amino acid incorporation
- Reproducible between batches
Limitations
- No chaperones (add separately)
- No post-translational modifications
- Lower yields than crude extracts
- Higher cost
When to Use PURE
- Unnatural amino acid incorporation
- Studying translation mechanisms
- "Clean" proteins needed
- Protease-sensitive targets
- Linear template expression
Common Artifacts and Solutions
Low Molecular Weight Bands
Causes: Premature termination, proteolysis, internal initiation
Solutions:
- Optimize rare codon clusters
- Add protease inhibitors
- Check for internal AUG codons
- Use PURE system
Higher MW Bands
Causes: Incomplete termination, read-through, aggregation
Solutions:
- Ensure strong stop codon (UAA preferred)
- Check template 3' end
- Add release factors (RF1/RF2)
- Reduce protein concentration
No Soluble Protein
Causes: Aggregation during synthesis
Solutions:
- Lower temperature (25°C → 18°C)
- Add chaperones
- Use solubility tag
- Optimize translation rate
References
CFPS Overview
Extract Preparation
PURE System
Wheat Germ
Codon Optimization
Disulfide Formation
Solubility Tags
Temperature Effects
Inputs
- A protein construct or sequence plus the intended expression objective and desired scale.
- Known liabilities such as disulfides, toxicity, membrane association, or aggregation.
- Available CFPS system options and readouts for yield or solubility.
Outputs
- A recommended CFPS platform, construct design guidance, and reaction optimization plan.
- Troubleshooting suggestions for low yield, precipitation, or inactive product.
- An experiment-ready checklist covering template design, additives, and controls.
Next Step
Run the recommended expression screen, then pair high-yield constructs with spr-bli-binding-characterization or structural validation.
1---2name: cell-free-protein-expression3description: Cell-free protein synthesis (CFPS) planning and optimization guidance. Use when: (1) Planning CFPS experiments, (2) Troubleshooting low yield or aggregation, (3) Optimizing DNA template design for CFPS, (4) Expressing difficult proteins (disulfide-rich, toxic, membrane).4license: MIT5---6
7# Cell-Free Protein Synthesis (CFPS)
8
9**Plain-language role**: Use this skill to plan expression screens and improve yield or solubility in cell-free systems.
10
11## System Selection Guide
12
13| System | Best For | Yield | PTMs | Disulfides | Cost |
14|--------|----------|-------|------|------------|------|
15| **E. coli extract** | Rapid prototyping, prokaryotic proteins | High (100-400 μg/mL) | None | Poor (reducing) | Low |
16| **E. coli PURE** | Defined conditions, unnatural AAs | Medium (50-150 μg/mL) | None | Controllable | High |
17| **Wheat germ** | Eukaryotic proteins, membrane proteins | High (100-500 μg/mL) | Limited | Moderate | Medium |
18| **Rabbit reticulocyte** | Mammalian proteins, post-translational studies | Low (10-50 μg/mL) | Some | Poor | High |
19| **Insect (Sf21)** | Glycoproteins, complex folds | Medium (50-100 μg/mL) | Glycosylation | Good | High |
20| **HeLa/CHO** | Native mammalian proteins | Low (10-50 μg/mL) | Full mammalian | Good | Very High |
21
22---
23
24## CFPS Troubleshooting Matrix
25
26| Problem | Likely Causes | Design Fix | Reagent Fix |
27|---------|---------------|------------|-------------|
28| **No expression** | Rare codons at N-terminus, poor RBS | Codon optimize first 30 codons | Use BL21-CodonPlus extract |
29| **Low yield** | Strong mRNA secondary structure, template issues | Optimize 5' UTR (ΔG > -5 kcal/mol) | Increase Mg²⁺ (10-18 mM), ATP |
30| **Aggregation** | Hydrophobic protein, fast translation | Add solubility tags (MBP, SUMO) | Add 0.1% Tween-20, chaperones |
31| **Inactive protein** | Misfolding, missing cofactors | Slow translation (use rare codons!) | Add GroEL/ES, DnaK/J |
32| **Truncation** | Rare codon clusters, mRNA instability | Remove AGG/AGA/CUA clusters | Supplement rare tRNAs |
33| **Degradation** | Proteolysis | N-terminal Met-Ala | Add protease inhibitors |
34
35---
36
37## Codon Optimization for CFPS
38
39### Codons to Avoid in E. coli CFPS
40
41| Codon | Amino Acid | Issue | tRNA Abundance |
42|-------|------------|-------|----------------|
43| AGG | Arg | Very rare, stalling | 0.2% |
44| AGA | Arg | Very rare, stalling | 0.4% |
45| CUA | Leu | Low abundance | 0.4% |
46| AUA | Ile | Rare | 0.5% |
47| CGA | Arg | Inefficient decoding | 0.6% |
48| CCC | Pro | Can cause pausing | 0.5% |
49| GGA | Gly | Moderate | 1.1% |
50
51### Design Rules
52
531. **First 30 codons**: Most critical - use only high-frequency codons
542. **Rare codon clusters**: Avoid 2+ rare codons within 10 nt
553. **Rare codon content**: Keep overall <5% of coding sequence
564. **GC content**: Target 40-60% for balanced expression
575. **Avoid runs**: No >6 consecutive G or C residues (secondary structure)
586. **Strategic slow codons**: Place rare codons between domains (aids folding!)
59
60### When to Use Rare Codons
61- Domain boundaries (allow cotranslational folding)
62- Before complex structural elements
63- When protein is prone to misfolding
64
65---
66
67## mRNA Template Design
68
69### 5' UTR Optimization
70
71| Element | Optimal Design | Impact |
72|---------|----------------|--------|
73| **RBS (SD sequence)** | AGGAGG, 7-9 nt from start | Ribosome binding |
74| **Spacing** | 7 nt between SD and AUG | Translation initiation |
75| **Secondary structure** | ΔG > -5 kcal/mol | Accessibility |
76| **Upstream AUG** | Avoid (causes false starts) | Reduces truncations |
77
78### Secondary Structure Targets
79
80| Region | Ideal ΔG | Impact |
81|--------|----------|--------|
82| -30 to +30 around AUG | > -5 kcal/mol | Translation initiation |
83| Full 5' UTR | > -10 kcal/mol | Ribosome loading |
84| RBS accessibility | Unpaired | Critical |
85
86### Template Format
87
88| Format | Advantages | Disadvantages |
89|--------|------------|---------------|
90| **Plasmid** | Stable, high yield | Requires cloning |
91| **Linear PCR** | Fast, no cloning | May need stabilization |
92| **mRNA** | Direct translation | Unstable, expensive |
93
94---
95
96## Disulfide Bond Formation
97
98### System Capabilities
99
100| System | Native Disulfide Support | Additives Needed |
101|--------|--------------------------|------------------|
102| Standard E. coli extract | Poor (DTT present) | IAM, PDI, GSSG/GSH |
103| Oxidizing E. coli extract | Good | Pre-oxidized glutathione |
104| Wheat germ | Moderate | Lower DTT, add PDI |
105| PURE system | Minimal | Full oxidative system |
106| Insect/Mammalian | Good | Microsome membranes |
107
108### Oxidative Folding Protocol (E. coli extract)
109
110```
1111. Deplete DTT from extract (dialysis or treatment with IAM 5 mM)
1122. Add oxidized/reduced glutathione: 4 mM GSSG, 1 mM GSH (4:1 ratio)
1133. Add 10 μM PDI (protein disulfide isomerase)
1144. Optional: Add 5 μM DsbC (disulfide isomerase)
1155. Express at 25°C (not 37°C) for better folding
1166. Incubation time: 4-6 hours
117```
118
119### Disulfide-Rich Protein Tips
120- Start with wheat germ or oxidizing extract
121- Use PURE system for precise control
122- Consider co-expression of PDI/DsbC
123- Verify by non-reducing SDS-PAGE
124
125---
126
127## Expression Prediction from Sequence
128
129| Feature | Good | Marginal | Bad |
130|---------|------|----------|-----|
131| **Rare codon content** | <3% | 3-8% | >10% |
132| **First 30 codons rare** | 0 | 1-2 | >2 |
133| **GC content** | 45-55% | 35-45% or 55-65% | <30% or >70% |
134| **5' UTR ΔG** | > -3 kcal/mol | -3 to -8 | < -10 kcal/mol |
135| **Hydrophobic stretches** | <5 consecutive | 5-7 | >8 consecutive |
136| **N-terminal residue** | Met-Ala, Met-Ser, Met-Gly | Met-Val, Met-Thr | Met-Arg, Met-Lys |
137| **Cysteine pairs** | Paired (even number) | Mixed | Odd number (free thiols) |
138
139---
140
141## Solubility Enhancement Strategies
142
143### Fusion Tags (ranked by effectiveness)
144
145| Tag | Size | Solubility Enhancement | Cleavage | Notes |
146|-----|------|------------------------|----------|-------|
147| **MBP** | 40 kDa | Excellent | TEV, Factor Xa | Best overall |
148| **SUMO** | 11 kDa | Very Good | SUMO protease | Native N-terminus after cleavage |
149| **NusA** | 55 kDa | Excellent | - | Large size |
150| **Trx** | 12 kDa | Good | Enterokinase | For disulfide proteins |
151| **GST** | 26 kDa | Moderate | - | Dimeric |
152| **His₆** | 1 kDa | Minimal | - | Mainly for purification |
153
154### Buffer Additives for Solubility
155
156| Additive | Concentration | Mechanism |
157|----------|---------------|-----------|
158| Trehalose | 50-100 mM | Chemical chaperone |
159| Glycerol | 5-10% | Reduces hydrophobic aggregation |
160| L-Arginine | 50-100 mM | Suppresses aggregation |
161| Tween-20 | 0.05-0.1% | Prevents surface adsorption |
162| Proline | 50 mM | Osmolyte stabilization |
163
164### Chaperone Supplementation
165
166| Chaperone System | Target Problem | Concentration |
167|------------------|----------------|---------------|
168| GroEL/GroES | General folding | 1-2 μM |
169| DnaK/DnaJ/GrpE | Aggregation-prone | 1 μM each |
170| Trigger Factor | Nascent chain | 1-2 μM |
171| ClpB | Aggregate resolubilization | 0.5 μM |
172
173---
174
175## Temperature Optimization
176
177| Temperature | Use Case | Trade-offs |
178|-------------|----------|------------|
179| **37°C** | Fast expression, stable proteins | Higher aggregation risk |
180| **30°C** | Balanced (default) | Good compromise |
181| **25°C** | Disulfide proteins, complex folds | Slower, better folding |
182| **18-20°C** | Aggregation-prone proteins | Much slower, best folding |
183| **16°C** | Cold-shock proteins | Very slow, specialized |
184
185---
186
187## E. coli Extract Preparation (Key Variables)
188
189| Variable | Impact | Optimal Range |
190|----------|--------|---------------|
191| **Cell density at harvest** | Ribosome content | OD₆₀₀ 2.5-3.5 |
192| **Lysis method** | Extract activity | Sonication, bead beating |
193| **Run-off reaction** | Removes endogenous mRNA | 20-80 min at 37°C |
194| **Mg²⁺ concentration** | Translation fidelity | 10-18 mM |
195| **K⁺ concentration** | Translation rate | 150-200 mM |
196| **Energy system** | Sustained synthesis | ATP/GTP, creatine phosphate |
197
198---
199
200## PURE System Specifics
201
202### Advantages
203- Defined composition (no proteases/nucleases)
204- Linear DNA templates work well
205- Unnatural amino acid incorporation
206- Reproducible between batches
207
208### Limitations
209- No chaperones (add separately)
210- No post-translational modifications
211- Lower yields than crude extracts
212- Higher cost
213
214### When to Use PURE
215- Unnatural amino acid incorporation
216- Studying translation mechanisms
217- "Clean" proteins needed
218- Protease-sensitive targets
219- Linear template expression
220
221---
222
223## Common Artifacts and Solutions
224
225### Low Molecular Weight Bands
226**Causes**: Premature termination, proteolysis, internal initiation
227**Solutions**:
228- Optimize rare codon clusters
229- Add protease inhibitors
230- Check for internal AUG codons
231- Use PURE system
232
233### Higher MW Bands
234**Causes**: Incomplete termination, read-through, aggregation
235**Solutions**:
236- Ensure strong stop codon (UAA preferred)
237- Check template 3' end
238- Add release factors (RF1/RF2)
239- Reduce protein concentration
240
241### No Soluble Protein
242**Causes**: Aggregation during synthesis
243**Solutions**:
244- Lower temperature (25°C → 18°C)
245- Add chaperones
246- Use solubility tag
247- Optimize translation rate
248
249---
250
251## References
252
253### CFPS Overview
254- [User's Guide to CFPS - PMC](https://pmc.ncbi.nlm.nih.gov/articles/PMC6481089/)
255- [Optimising Protein Synthesis in Cell-Free Systems - PMC](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9996726/)
256- [CFPS Systems Comparison - PMC](https://pmc.ncbi.nlm.nih.gov/articles/PMC8258279/)
257
258### Extract Preparation
259- [Crude Extract Preparation - MDPI Methods](https://www.mdpi.com/2409-9279/2/3/68)
260- [Simple Rapid Cell-Free Lysate - PLOS One](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0165137)
261- [High-Throughput Extract Preparation - Nature Scientific Reports](https://www.nature.com/articles/srep08663)
262
263### PURE System
264- [PURE System Evolution - PMC](https://pmc.ncbi.nlm.nih.gov/articles/PMC10521753/)
265- [PURE System for Membrane Proteins - Nature Protocols](https://www.nature.com/articles/nprot.2015.082)
266
267### Wheat Germ
268- [Wheat Germ Systems Review - FEBS Letters](https://febs.onlinelibrary.wiley.com/doi/10.1016/j.febslet.2014.05.061)
269- [Wheat Germ for Structural Biology - PMC](https://pmc.ncbi.nlm.nih.gov/articles/PMC8027086/)
270
271### Codon Optimization
272- [Rare Codons and Solubility - PMC](https://pmc.ncbi.nlm.nih.gov/articles/PMC2723077/)
273- [Codon Influence on Expression - Nature](https://www.nature.com/articles/nature16509)
274- [Synonymous Codon Substitutions Perturb Folding - PNAS](https://www.pnas.org/doi/10.1073/pnas.1907126117)
275
276### Disulfide Formation
277- [Oxidative Protein Folding in ER - PMC](https://pmc.ncbi.nlm.nih.gov/articles/PMC4312752/)
278- [PDI-Regulated Disulfide Formation - PMC](https://pmc.ncbi.nlm.nih.gov/articles/PMC7794689/)
279
280### Solubility Tags
281- [SUMO Fusion for Difficult Proteins - PMC](https://pmc.ncbi.nlm.nih.gov/articles/PMC7129290/)
282- [Fusion Tags Review - Frontiers Microbiol](https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2014.00063/full)
283
284### Temperature Effects
285- [Cold Shock Promoters - PMC](https://pmc.ncbi.nlm.nih.gov/articles/PMC9800685/)
286- [Strategies to Optimize E. coli Expression - PMC](https://pmc.ncbi.nlm.nih.gov/articles/PMC7162232/)
287
288## Inputs
289
290- A protein construct or sequence plus the intended expression objective and desired scale.
291- Known liabilities such as disulfides, toxicity, membrane association, or aggregation.
292- Available CFPS system options and readouts for yield or solubility.
293
294## Outputs
295
296- A recommended CFPS platform, construct design guidance, and reaction optimization plan.
297- Troubleshooting suggestions for low yield, precipitation, or inactive product.
298- An experiment-ready checklist covering template design, additives, and controls.
299
300## Next Step
301
302Run the recommended expression screen, then pair high-yield constructs with `spr-bli-binding-characterization` or structural validation.